Type IA variation for application PMDA-2022-0043. Type IA variation: New Dosage Strength for Tiotropizone — critical change

Variation Number
PMDA-2022-0043-V343
Type
Type IA
Application
Status
In Progress
Fee
€4,530
Submitted
—
Approved
—
Description

Type IA variation: New Dosage Strength for Tiotropizone — critical change